Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH rare diseases coordinator

Executive Summary

HHS Assistant Secretary for Health Mason announced at May 3 meeting on rare diseases that Stephen Groft, formerly with FDA's Office of Orphan Products, is being appointed coordinator for rare disease activities at the National Institutes of Health. Groft will work with a network of about 20 staff members who have been designated as focal points for rare disease research within NIH, Mason said. Groft also will work with FDA on developing implementation plans for recommendations made by the National Commission on Orphan Diseases.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS017386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel